Australia markets open in 6 hours 1 minute

Nephros, Inc. (NEPH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.0800-0.1900 (-8.37%)
As of 01:58PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close2.2700
Open2.2800
Bid2.0700 x 3000
Ask2.1000 x 2200
Day's range1.8900 - 2.4180
52-week range1.8900 - 11.6700
Volume842,339
Avg. volume49,465
Market cap21.463M
Beta (5Y monthly)1.24
PE ratio (TTM)N/A
EPS (TTM)-0.4100
Earnings date03 Aug 2022 - 08 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est7.63
  • GlobeNewswire

    Nephros Receives FDA 510(k) Clearance for HDF Assist Module

    The First and Only FDA-Cleared Device Available in the United States to Provide Hemodiafiltration Therapy to Dialysis Patients SOUTH ORANGE, NJ, May 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it has received FDA 510(k) clearance for its patented, second-generation HDF Assist Module. The HDF Assist Module is the fir

  • GlobeNewswire

    Nephros Announces Results for Quarter Ended March 31, 2022

    First Quarter Net Revenue of $2.2 Million;Active Customer Sites Climb 17% to New Record SOUTH ORANGE, NJ, May 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced financial results for the first quarter ended March 31, 2022. Financial Highlights Water Filtration Business Segment Highlights* Net revenue of $2.2 million, a decrease

  • GlobeNewswire

    Nephros First Quarter 2022 Financial Results Conference Call

    SOUTH ORANGE, NJ, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results on Wednesday, May 4, 2022 after market close and will host a conference call that same day at 4:30 PM ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International